Corrigendum to “The potential molecular pathways of astragaloside-IV in colorectal cancer: A systematic review” [Biomed. Pharmacother. 167 (2023) 115625]
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-12-01
|
Series: | Biomedicine & Pharmacotherapy |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332223015858 |
_version_ | 1797630619394506752 |
---|---|
author | Tang Ziyang Hu Xirong An Chongming Li Tingxin |
author_facet | Tang Ziyang Hu Xirong An Chongming Li Tingxin |
author_sort | Tang Ziyang |
collection | DOAJ |
first_indexed | 2024-03-11T11:10:44Z |
format | Article |
id | doaj.art-95d8d89d5f3249218a47709cee00609d |
institution | Directory Open Access Journal |
issn | 0753-3322 |
language | English |
last_indexed | 2024-03-11T11:10:44Z |
publishDate | 2023-12-01 |
publisher | Elsevier |
record_format | Article |
series | Biomedicine & Pharmacotherapy |
spelling | doaj.art-95d8d89d5f3249218a47709cee00609d2023-11-12T04:39:19ZengElsevierBiomedicine & Pharmacotherapy0753-33222023-12-01168115787Corrigendum to “The potential molecular pathways of astragaloside-IV in colorectal cancer: A systematic review” [Biomed. Pharmacother. 167 (2023) 115625]Tang Ziyang0Hu Xirong1An Chongming2Li Tingxin3Department of Health Management & Institute of Health Management, Sichuan Provincial People’s Hospital, Chengdu, PR China; School of Medicine, University of Electronic Science and Technology of China, Chengdu, PR ChinaFaculty of Nursing, Xi’an Jiaotong University, Xi’an, PR ChinaDepartment of Health Management & Institute of Health Management, Sichuan Provincial People’s Hospital, Chengdu, PR China; School of Medicine, University of Electronic Science and Technology of China, Chengdu, PR China; Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, PR ChinaDepartment of Health Management & Institute of Health Management, Sichuan Provincial People’s Hospital, Chengdu, PR China; School of Medicine, University of Electronic Science and Technology of China, Chengdu, PR China; Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, PR China; Corresponding author at: Department of Health Management & Institute of Health Management, Sichuan Provincial People’s Hospital, Chengdu, PR China.http://www.sciencedirect.com/science/article/pii/S0753332223015858 |
spellingShingle | Tang Ziyang Hu Xirong An Chongming Li Tingxin Corrigendum to “The potential molecular pathways of astragaloside-IV in colorectal cancer: A systematic review” [Biomed. Pharmacother. 167 (2023) 115625] Biomedicine & Pharmacotherapy |
title | Corrigendum to “The potential molecular pathways of astragaloside-IV in colorectal cancer: A systematic review” [Biomed. Pharmacother. 167 (2023) 115625] |
title_full | Corrigendum to “The potential molecular pathways of astragaloside-IV in colorectal cancer: A systematic review” [Biomed. Pharmacother. 167 (2023) 115625] |
title_fullStr | Corrigendum to “The potential molecular pathways of astragaloside-IV in colorectal cancer: A systematic review” [Biomed. Pharmacother. 167 (2023) 115625] |
title_full_unstemmed | Corrigendum to “The potential molecular pathways of astragaloside-IV in colorectal cancer: A systematic review” [Biomed. Pharmacother. 167 (2023) 115625] |
title_short | Corrigendum to “The potential molecular pathways of astragaloside-IV in colorectal cancer: A systematic review” [Biomed. Pharmacother. 167 (2023) 115625] |
title_sort | corrigendum to the potential molecular pathways of astragaloside iv in colorectal cancer a systematic review biomed pharmacother 167 2023 115625 |
url | http://www.sciencedirect.com/science/article/pii/S0753332223015858 |
work_keys_str_mv | AT tangziyang corrigendumtothepotentialmolecularpathwaysofastragalosideivincolorectalcancerasystematicreviewbiomedpharmacother1672023115625 AT huxirong corrigendumtothepotentialmolecularpathwaysofastragalosideivincolorectalcancerasystematicreviewbiomedpharmacother1672023115625 AT anchongming corrigendumtothepotentialmolecularpathwaysofastragalosideivincolorectalcancerasystematicreviewbiomedpharmacother1672023115625 AT litingxin corrigendumtothepotentialmolecularpathwaysofastragalosideivincolorectalcancerasystematicreviewbiomedpharmacother1672023115625 |